FMI
COGT icon

F/M Investments’s Cogent Biosciences COGT Stock Holding History

F/M Investments’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.85M Buy
228,688
+2,546
+1% +$89.1K 0.45% 49
2026
Q1 		$8.7M Sell
226,142
-9,662
-4% -$357K 0.58% 45
2025
Q4 		$8.38M Buy
235,804
+15,636
+7% +$440K 0.32% 74
2025
Q3 		$3.16M Buy
220,168
+100,157
+83% +$1.19M 0.12% 182
2025
Q2 		$862K Buy
+120,011
New +$665K 0.03% 302

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

F/M Investments's COGT Position: Q2 2026 in Review

F/M Investments increased its Cogent Biosciences (COGT) stake by 1.1% in Q2 2026, buying an estimated $89.1K and bringing the position to 228,688 shares worth $8.85M. The position accounts for 0.45% of the portfolio, ranked #49.

F/M Investments first reported a position in COGT in Q2 2025 and has held it in 5 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • F/M Investments held 228,688 shares of Cogent Biosciences worth $8.85M as of Q2 2026.
  • F/M Investments bought 2,546 Cogent Biosciences shares in Q2 2026, an estimated $89.1K.
  • Cogent Biosciences made up 0.45% of F/M Investments's portfolio in Q2 2026, its #49 holding.
  • F/M Investments first reported a position in Cogent Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.